Semprus Biosciences of Cambridge was another life science company spun out of an MIT lab in 2005. Its founders spent the next seven years building a company and developing a real product, then sold Semprus on Monday for as much as $80 million. The Semprus story illustrates the business challenges and opportunities scores of young life science companies face when they try to grow a business.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help